Skip to content

Study of efficacy of Yokuinin in cervical dysplasia

Study of efficacy of Yokuinin in cervical dysplasia - Study of efficacy of Yokuinin in cervical dysplasia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017933
Enrollment
60
Registered
2015-06-17
Start date
2015-06-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients diagnosed with cervical dysplasia(CIN1 or CIN2) in cervical cancer screening

Interventions

Sponsors

Fushiki Clinic
Lead Sponsor
1.Saiseikai Takaoka Hospital 2.Ladies&#39
Collaborator
Clinic We!TOYAMA
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Cervical cancer screening was diagnosed with cervical dysplasia in meet the following condition. 1.Paients diagnosed with CIN1,CIN2 in cervical biopsy. 2.Patients who are not pregnant or breastfeeding. 3.Patients who will be able to obtain written informed consent.

Exclusion criteria

Exclusion criteria: 1.Who has a serious diseases. 2.Patients who were judged to be inappropriate for the study by the investigator. 3.Those who have a history of cervical dysplasia or surgery by it.

Design outcomes

Primary

MeasureTime frame
1.Cervical cytology 2.HPV-genotyping test

Countries

Japan

Contacts

Public ContactHiroshi Fushiki

Fushiki Clinic Director

fsk@p1.tst.ne.jp0763-32-2275

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026